VP of BD at SK pharmteco. After 20 years in technical and BD roles at GSK, Amgen and Array Biopharma, I joined AMPAC Fine Chemicals in 2014. AMPAC was acquired in 2018 by SK. My focus is on growing SK's small molecule CDMO business. We have R&D and GMP manufacturing sites in the US, Korea and Ireland.